T

TAK

Takeda Pharm

14.27

0.04+0.28%
After Hours: 14.26  -0.01  -0.07%18:32 05/20 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Total Revenue

4.58T

4.26T

4.03T

3.57T

3.20T

Net Income

107.93B

144.07B

317.02B

230.06B

376.00B

ROE

0.0152

0.0211

0.0527

0.0424

0.0759

ROA

0.0074

0.0099

0.0234

0.0176

0.0292

EPS

34.1788

46.044

100.9691

72.9342

119.4776

BVPS

2.20K

2.32K

2.04K

1.83K

1.65K

Asset Turnover

0.3121

0.2934

0.2968

0.2736

0.2485

Debt-to-Asset

0.5132

0.5186

0.5447

0.5687

0.5991

Current Ratio

1.0059

1.1061

0.9662

1.2087

1.53

Quick Ratio

0.5202

0.5831

0.5687

0.8111

1.1048